DK675388A - Diagnosticering af fedme foraarsaget af en genetisk abnormitet og fremgangsmaade til terapeutisk behandling af genetisk betinget fedme - Google Patents

Diagnosticering af fedme foraarsaget af en genetisk abnormitet og fremgangsmaade til terapeutisk behandling af genetisk betinget fedme

Info

Publication number
DK675388A
DK675388A DK675388A DK675388A DK675388A DK 675388 A DK675388 A DK 675388A DK 675388 A DK675388 A DK 675388A DK 675388 A DK675388 A DK 675388A DK 675388 A DK675388 A DK 675388A
Authority
DK
Denmark
Prior art keywords
genetic
obesis
diagnostication
abnormity
obese
Prior art date
Application number
DK675388A
Other languages
English (en)
Other versions
DK675388D0 (da
Inventor
Jeffrey S Flier
Bruce M Spiegelman
Original Assignee
Beth Israel Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Hospital filed Critical Beth Israel Hospital
Publication of DK675388A publication Critical patent/DK675388A/da
Publication of DK675388D0 publication Critical patent/DK675388D0/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/042Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/044Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK675388A 1987-04-02 1988-12-02 Diagnosticering af fedme foraarsaget af en genetisk abnormitet og fremgangsmaade til terapeutisk behandling af genetisk betinget fedme DK675388D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3420387A 1987-04-02 1987-04-02
PCT/US1988/000999 WO1988007681A1 (en) 1987-04-02 1988-03-29 Diagnosing obesity caused by a genetic abnormality and method of therapeutically treating genetically caused obesity

Publications (2)

Publication Number Publication Date
DK675388A true DK675388A (da) 1988-12-02
DK675388D0 DK675388D0 (da) 1988-12-02

Family

ID=21874944

Family Applications (1)

Application Number Title Priority Date Filing Date
DK675388A DK675388D0 (da) 1987-04-02 1988-12-02 Diagnosticering af fedme foraarsaget af en genetisk abnormitet og fremgangsmaade til terapeutisk behandling af genetisk betinget fedme

Country Status (13)

Country Link
EP (2) EP0382720B1 (da)
JP (1) JPH02503229A (da)
AT (1) ATE80465T1 (da)
AU (1) AU606946B2 (da)
DE (1) DE3874543T2 (da)
DK (1) DK675388D0 (da)
ES (1) ES2046325T3 (da)
FI (1) FI894592A (da)
GR (1) GR3005716T3 (da)
IL (1) IL85897A0 (da)
NO (1) NO885360L (da)
WO (1) WO1988007681A1 (da)
ZA (1) ZA882288B (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8087591A (en) * 1990-06-01 1991-12-31 W. Alton Jones Cell Science Center Mammalian adipogenic factors
EP1578367A4 (en) * 2002-11-01 2012-05-02 Genentech Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE DISEASES
WO2015138309A1 (en) 2014-03-13 2015-09-17 Dana-Farber Cancer Institute, Inc. Compositions and methods for regulating pancreatic beta cell function using adipsin
DE102014107380A1 (de) 2014-05-26 2015-11-26 Eberhard Karls Universität Tübingen Medizinische Fakultät Verfahren zur Diagnose einer durch den alternativen Weg des Komplementsystems vermittelten Krankheit oder eines Risikos hierfür

Also Published As

Publication number Publication date
NO885360D0 (no) 1988-12-01
EP0382720A1 (en) 1990-08-22
EP0287509B1 (en) 1992-09-16
AU606946B2 (en) 1991-02-21
EP0287509A1 (en) 1988-10-19
ATE80465T1 (de) 1992-09-15
EP0382720A4 (en) 1991-01-02
IL85897A0 (en) 1988-09-30
DK675388D0 (da) 1988-12-02
DE3874543D1 (de) 1992-10-15
JPH02503229A (ja) 1990-10-04
WO1988007681A1 (en) 1988-10-06
DE3874543T2 (de) 1993-02-04
AU1591388A (en) 1988-11-02
EP0382720B1 (en) 1992-09-09
ES2046325T3 (es) 1994-02-01
FI894592A0 (fi) 1989-09-28
FI894592A (fi) 1989-09-28
NO885360L (no) 1989-02-01
ZA882288B (en) 1988-12-28
GR3005716T3 (da) 1993-06-07

Similar Documents

Publication Publication Date Title
ATE295176T1 (de) Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen
ATE269978T1 (de) Verfahren zur bestimmung der prognose eines patienten mit einer neurologischen krankheit
FI872756A (fi) Med laserstraolning fungerande terapeutisk anordning.
MX9605176A (es) Polimorfismo de apolipoproteina e y tratamiento de la enfermedad de alzheimer.
DE3681883D1 (de) System zum sammeln, behandeln und zurueckfuehren des blutes eines patienten.
EP0376251A3 (en) An anticoagulant substance obtained from urine
PT86346A (en) Method of treatment by means of the 3:-deoxitimidinene-2:(3:deoxi-2:3:-didesidrotimidine) administration to animals of hot blood infected with retrovirus
DE3855527D1 (de) Doppelsträngige RNS zur Korrektur von Abnormalitäten von zirkulierenden Immunkomplexen und der Monozytenfunktion
DE69228824D1 (de) NACHWEISMETHODEN FÜR C-Raf-1-GENES.5
DK675388A (da) Diagnosticering af fedme foraarsaget af en genetisk abnormitet og fremgangsmaade til terapeutisk behandling af genetisk betinget fedme
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
NO152484C (no) Anordning for aa skille ut fra en biologisk vaeske, saerlig blod, en fraksjon med molekylvekt mellom en oevre og en nedre grenseverdi
Uchino et al. Effects of peptic digestion, pH change and heating on B12 binders in the electrophoretic partition of the human gastric juice
DE3572033D1 (en) Method for diagnosis of a.i.d.s.
Smith The Interpretation of Plasma Haloperidol Concentrations-Reply
IT9041714A0 (it) Linfa del libro dell'abete rosso (abies picea) per la cura di malattie neoplastiche e da virus in genere
ATE530651T1 (de) Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose
IT8819818A0 (it) Metodo per il controllo quantitativo del mutamento di posizione o il riposizionamento di pazienti nel rilievo di immagini radiografiche e/o in terapie per irraggiamento.
UA10359A (uk) Спосіб визhачеhhя показhиків до призhачеhhя аhтагоhістів кальцію у хворих ішемічhою хворобою серця
UA6102A1 (uk) Спосіб визначення індивідуальної чутливості хворих до кемантану при хронічному обструктивному бронхіті
DK226688D0 (da) Middel til behandling og forebyggelse af asthma

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment